AU - 
TI - Real-world efficacy and safety of risankizumab in moderate-to-severe psoriasis: experience from a tertiary center
PT - Journal Article
DP - 2024
TA - Anales Médicos
AID - 10.24875/PJDV.25000036 [doi]